Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Verboom MC"'
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. m.c.verboom@lumc.nl., Kloth JSL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2019 Oct; Vol. 19 (5), pp. 473-479. Date of Electronic Publication: 2019 Feb 04.
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands., Kerst JM; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, Netherlands., Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, P.O. Box 5201, 3008 AE Rotterdam, Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, Netherlands., van den Hout WB; Department of Medical Decision Making, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands.
Publikováno v:
Sarcoma [Sarcoma] 2019 Jun 02; Vol. 2019, pp. 3234205. Date of Electronic Publication: 2019 Jun 02 (Print Publication: 2019).
Autor:
Kloth JSL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Verboom MC; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., van der Straaten T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2018 Jan; Vol. 18 (1), pp. 49-55. Date of Electronic Publication: 2017 Jan 24.
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.c.verboom@lumc.nl., Kloth JSL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., van der Straaten T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Steeghs N; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Nov; Vol. 86, pp. 226-232. Date of Electronic Publication: 2017 Oct 18.
Autor:
Verboom MC; Departments of aMedical Oncology bClinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden cCentral Hospital Pharmacy dDepartment of Hospital Pharmacy eDepartment of Hematology, Haga Teaching Hospital, The Hague fDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam gHospital Pharmacy hDepartment of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands., Visser L, Kouwen S, Swen JJ, Diepstraten J, Posthuma WF, Gelderblom H, van Lammeren D, Wilms EB
Publikováno v:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2017 Jun; Vol. 27 (6), pp. 223-226.
Autor:
Verboom MC; Department of Medical Oncology, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands., Ouwerkerk J; Department of Medical Oncology, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands., Steeghs N; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands., Lutjeboer J; Department of Radiology, Interventional Radiology Section, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands., Martijn Kerst J; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands.; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, 123 Old Brompton Road, London, SW7 3RP UK., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Postbus 30.001, 9700 RB Groningen, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Postbus 2040, 3000 CA Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands.
Publikováno v:
Clinical sarcoma research [Clin Sarcoma Res] 2017 Jan 31; Vol. 7, pp. 2. Date of Electronic Publication: 2017 Jan 31 (Print Publication: 2017).
Autor:
Tieken C, Verboom MC, Ruf W, Gelderblom H, Bovée JV, Reitsma PH, Cleton-Jansen AM, Versteeg HH; Henri H. Versteeg, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands, Tel.: +31 715263872, Fax: +31 71526755, E-mail: h.h.versteeg@lumc.nl.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2016 May 02; Vol. 115 (5), pp. 1025-33. Date of Electronic Publication: 2016 Jan 14.
Autor:
Kloth JS; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3075EA Rotterdam, The Netherlands., Pagani A; Department of Medical Oncology, Fondazione S. Maugeri, Via Maugeri 10, 27100 Pavia, Italy., Verboom MC; Department of Clinical Oncology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands., Malovini A; Laboratory of Informatics and Systems Engineering for Clinical Research, Salvatore Maugeri Research and Care Institute, Pavia, Italy., Napolitano C; Department of Molecular Cardiology, IRCCS Fondazione S. Maugeri, Via Maugeri 10, 27100 Pavia, Italy., Kruit WH; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3075EA Rotterdam, The Netherlands., Sleijfer S; 1] Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3075EA Rotterdam, The Netherlands [2] Cancer Genomics Netherlands, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006 BE Amsterdam, The Netherlands., Zambelli A; Department of Medical Oncology, Ospedale Papa Giovanni XXIII, P.zza OMS n 1, 24127 Bergamo, Italy., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3075EA Rotterdam, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2015 Mar 17; Vol. 112 (6), pp. 1011-6. Date of Electronic Publication: 2015 Mar 17.
Autor:
Krens LL; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600 NL, 2300 RC, Leiden, The Netherlands, l.l.krens@lumc.nl., Baas JM, Verboom MC, Paintaud G, Desvignes C, Guchelaar HJ, Gelderblom H
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2014 Jun; Vol. 73 (6), pp. 1303-6. Date of Electronic Publication: 2014 Apr 06.